Migraine Drugs Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Migraine Drugs Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Migraine Drugs Market Research
Report The latest report by IMARC, titled
Migraine Drugs Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 the global migraine drugs market is
expected to grow at a CAGR of 4.5 during
2023-2028. Migraine drugs refer to medications
that are used to reduce the severity of migraines
and prevent future attacks. A migraine is a
severe, neurological disease with a debilitating
headache, characterized by an intense throbbing
or pulsing in one area of the head. It is
accompanied by sensitivity to light, sound and
smell, visual disturbances such as auras, and
nausea or vomiting. Migraine drugs do not cure
migraines instead, they treat or relieve these
symptoms. There are certain blood pressure
medications, as well as some antidepressants,
anti-seizure drugs and herbals that are used to
reduce the frequency of migraines. Request Free
Sample Report https//www.imarcgroup.com/migraine
-drugs-market/requestsample
4
Report Description and Highlights
Report Description

Global Migraine Drugs Market Trends According
to the Migraine Trust, migraine is the third most
common disease globally, with more than 10 of
people getting affected by the condition
worldwide. This represents the primary factor
that has increased the demand for migraine drugs
across the globe. Apart from this, the rising
healthcare expenditure and improving
reimbursement policies for migraine medications
are also acting as growth-inducing factors.
Besides this, healthcare providers have made
significant advancements in the diagnosis and
treatment of migraine. A more advanced treatment
modality with mechanism-based therapies,
including supraorbital transcutaneous stimulation
(STS) and transcranial magnetic stimulation, has
been introduced as a preventive therapy for
migraine. Additionally, there are many other
drugs with novel mechanisms of action or new
therapeutic targets, which are in different
development stages. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Treatment Type
Abortive Treatment Preventive Treatm
ent Breakup by Drug Type Triptans
Ergot Alkaloids NSAIDs A
cetylcholine Inhibitors/ Neurotoxins
Ditans CGRP mAbs Oth
ers Breakup by Route of Administration
Oral Injectable Others

6
Report Description and Highlights
Report Description
Breakup by Distribution Channel
Hospital-Based Pharmacies
Retail Pharmacies Others Brea
kup by Region North America
United States Canada
Asia Pacific China
Japan India
South Korea Australia
Indonesia Other
s Europe Germany
France

7
Report Description and Highlights
Report Description
United Kingdom
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories Allergan Plc (Abbvie Inc.) Amg
  en Inc. AstraZeneca Plc Bausch Health Companies In
  c. (formerly Valeant Pharmaceuticals)
  Eisai Co. Ltd. Eli Lilly and Company Endo Internat
  ional Plc GlaxoSmithKline Plc Johnson Johnson Me
  rck Co. Novartis AG Pfizer Inc. Sanofi SA Teva P
  harmaceutical Industries Limited
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/migraine-drugs-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us